Literature DB >> 20164183

A novel protease-activated receptor-1 interactor, Bicaudal D1, regulates G protein signaling and internalization.

Steven Swift1, Jian Xu, Vishal Trivedi, Karyn M Austin, Sarah L Tressel, Lei Zhang, Lidija Covic, Athan Kuliopulos.   

Abstract

Protease-activated receptor-1 (PAR1) is a G protein-coupled receptor that plays critical roles in cancer, angiogenesis, inflammation, and thrombosis. Proteolytic cleavage of the extracellular domain of PAR1 generates a tethered ligand that activates PAR1 in an unusual intramolecular mode. The signal emanating from the irreversibly cleaved PAR1 is terminated by G protein uncoupling and internalization; however, the mechanisms of PAR1 signal shut off still remain unclear. Using a yeast two-hybrid screen, we identified Bicaudal D1 (BicD1) as a direct interactor with the C-terminal cytoplasmic domain of PAR1. BICD was originally identified as an essential developmental gene associated with mRNA and Golgi-endoplasmic reticulum transport. We discovered a novel function of BicD1 in the modulation of G protein signaling, cell proliferation, and endocytosis downstream of PAR1. BicD1 and its C-terminal CC3 domain inhibited PAR1 signaling to G(q)-phospholipase C-beta through coiled-coil interactions with the cytoplasmic 8th helix of PAR1. Unexpectedly, BicD1 was also found to be a potent suppressor of PAR1-driven proliferation of breast carcinoma cells. The growth-suppressing effects of BicD1 required the ability to interact with the 8th helix of PAR1. Silencing of BicD1 expression impaired endocytosis of PAR1, and BicD1 co-localized with PAR1 and tubulin, implicating BicD1 as an important adapter protein involved in the transport of PAR1 from the plasma membrane to endosomal vesicles. Together, these findings provide a link between PAR1 signal termination and internalization through the non-G protein effector, BicD1.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20164183      PMCID: PMC2857018          DOI: 10.1074/jbc.M110.105403

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  40 in total

Review 1.  Signaling at zero G: G-protein-independent functions for 7-TM receptors.

Authors:  J A Brzostowski; A R Kimmel
Journal:  Trends Biochem Sci       Date:  2001-05       Impact factor: 13.807

2.  Signaling from protease-activated receptor-1 inhibits migration and invasion of breast cancer cells.

Authors:  L Kamath; A Meydani; F Foss; A Kuliopulos
Journal:  Cancer Res       Date:  2001-08-01       Impact factor: 12.701

3.  Conserved signals and machinery for RNA transport in Drosophila oogenesis and embryogenesis.

Authors:  S L Bullock; D Ish-Horowicz
Journal:  Nature       Date:  2001-12-06       Impact factor: 49.962

4.  beta -Arrestins regulate protease-activated receptor-1 desensitization but not internalization or Down-regulation.

Authors:  May M Paing; Amy B Stutts; Trudy A Kohout; Robert J Lefkowitz; JoAnn Trejo
Journal:  J Biol Chem       Date:  2001-11-02       Impact factor: 5.157

5.  Protease-activated receptor-1 down-regulation: a mutant HeLa cell line suggests novel requirements for PAR1 phosphorylation and recruitment to clathrin-coated pits.

Authors:  J Trejo; Y Altschuler; H W Fu; K E Mostov; S R Coughlin
Journal:  J Biol Chem       Date:  2000-10-06       Impact factor: 5.157

6.  Purification, cloning, and characterization of Nek8, a novel NIMA-related kinase, and its candidate substrate Bicd2.

Authors:  Pamela M Holland; Alison Milne; Kirsten Garka; Richard S Johnson; Cynthia Willis; John E Sims; Charles T Rauch; Timothy A Bird; G Duke Virca
Journal:  J Biol Chem       Date:  2002-02-25       Impact factor: 5.157

7.  G protein-coupled receptor kinase-5 regulates thrombin-activated signaling in endothelial cells.

Authors:  C Tiruppathi; W Yan; R Sandoval; T Naqvi; A N Pronin; J L Benovic; A B Malik
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-20       Impact factor: 11.205

8.  Platelet matrix metalloprotease-1 mediates thrombogenesis by activating PAR1 at a cryptic ligand site.

Authors:  Vishal Trivedi; Adrienne Boire; Boris Tchernychev; Nicole C Kaneider; Andrew J Leger; Katie O'Callaghan; Lidija Covic; Athan Kuliopulos
Journal:  Cell       Date:  2009-04-17       Impact factor: 41.582

Review 9.  The role of beta-arrestins in the termination and transduction of G-protein-coupled receptor signals.

Authors:  Louis M Luttrell; Robert J Lefkowitz
Journal:  J Cell Sci       Date:  2002-02-01       Impact factor: 5.285

10.  beta-arrestin-dependent endocytosis of proteinase-activated receptor 2 is required for intracellular targeting of activated ERK1/2.

Authors:  K A DeFea; J Zalevsky; M S Thoma; O Déry; R D Mullins; N W Bunnett
Journal:  J Cell Biol       Date:  2000-03-20       Impact factor: 10.539

View more
  13 in total

Review 1.  Targeting proteinase-activated receptors: therapeutic potential and challenges.

Authors:  Rithwik Ramachandran; Farshid Noorbakhsh; Kathryn Defea; Morley D Hollenberg
Journal:  Nat Rev Drug Discov       Date:  2012-01-03       Impact factor: 84.694

2.  The more, the better: the BICD family gets bigger.

Authors:  Marco Terenzio; Giampietro Schiavo
Journal:  EMBO J       Date:  2010-05-19       Impact factor: 11.598

3.  A systems genetic analysis of alcohol drinking by mice, rats and men: influence of brain GABAergic transmission.

Authors:  Laura M Saba; Beth Bennett; Paula L Hoffman; Kelsey Barcomb; Takao Ishii; Katerina Kechris; Boris Tabakoff
Journal:  Neuropharmacology       Date:  2010-12-23       Impact factor: 5.250

Review 4.  Thrombin receptor antagonists for the treatment of atherothrombosis: therapeutic potential of vorapaxar and E-5555.

Authors:  Sergio Leonardi; Pierluigi Tricoci; Richard C Becker
Journal:  Drugs       Date:  2010-10-01       Impact factor: 9.546

5.  Interdicting protease-activated receptor-2-driven inflammation with cell-penetrating pepducins.

Authors:  Leila M Sevigny; Ping Zhang; Andrew Bohm; Katherine Lazarides; George Perides; Lidija Covic; Athan Kuliopulos
Journal:  Proc Natl Acad Sci U S A       Date:  2011-05-02       Impact factor: 11.205

6.  A follow-up study for left ventricular mass on chromosome 12p11 identifies potential candidate genes.

Authors:  David Della-Morte; Ashley Beecham; Tatjana Rundek; Liyong Wang; Mark S McClendon; Susan Slifer; Susan H Blanton; Marco R Di Tullio; Ralph L Sacco
Journal:  BMC Med Genet       Date:  2011-07-26       Impact factor: 2.103

7.  Thrombin-Induced Calpain Activation Promotes Protease-Activated Receptor 1 Internalization.

Authors:  Alejandro Alvarez-Arce; Irene Lee-Rivera; Edith López; Arturo Hernández-Cruz; Ana María López-Colomé
Journal:  Int J Cell Biol       Date:  2017-11-09

8.  PAR1 biased signaling is required for activated protein C in vivo benefits in sepsis and stroke.

Authors:  Ranjeet K Sinha; Yaoming Wang; Zhen Zhao; Xiao Xu; Laurent Burnier; Naveen Gupta; José A Fernández; Greg Martin; Sergey Kupriyanov; Laurent O Mosnier; Berislav V Zlokovic; John H Griffin
Journal:  Blood       Date:  2018-01-17       Impact factor: 25.476

9.  Protein biomarkers distinguish between high- and low-risk pediatric acute lymphoblastic leukemia in a tissue specific manner.

Authors:  Maria Braoudaki; George I Lambrou; Konstantinos Vougas; Kalliopi Karamolegou; George T Tsangaris; Fotini Tzortzatou-Stathopoulou
Journal:  J Hematol Oncol       Date:  2013-07-12       Impact factor: 17.388

10.  Mutations in BICD2 cause dominant congenital spinal muscular atrophy and hereditary spastic paraplegia.

Authors:  Emily C Oates; Alexander M Rossor; Majid Hafezparast; Michael Gonzalez; Fiorella Speziani; Daniel G MacArthur; Monkol Lek; Ellen Cottenie; Mariacristina Scoto; A Reghan Foley; Matthew Hurles; Henry Houlden; Linda Greensmith; Michaela Auer-Grumbach; Thomas R Pieber; Tim M Strom; Rebecca Schule; David N Herrmann; Janet E Sowden; Gyula Acsadi; Manoj P Menezes; Nigel F Clarke; Stephan Züchner; Francesco Muntoni; Kathryn N North; Mary M Reilly
Journal:  Am J Hum Genet       Date:  2013-05-09       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.